NASDAQ | ETF
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 7.16% |
BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 7.06% |
RDNT | RadNet Inc | Healthcare | Diagnostics & Research | 6.06% |
MMSI | Merit Medical Systems Inc | Healthcare | Medical Instruments & Supplies | 6.03% |
BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 5.92% |
TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 5.32% |
LIVN | LivaNova PLC | Healthcare | Medical Devices | 4.98% |
COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.73% |
RARE | Ultragenyx | Healthcare | Biotechnology | 4.08% |
MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 4.01% |
INSM | Insmed Inc | Healthcare | Biotechnology | 3.90% |
WVE | Wave Life Sciences Ltd | Healthcare | Biotechnology | 3.85% |
ATEC | Alphatec Holdings Inc | Healthcare | Medical Devices | 3.58% |
TMDX | TransMedics Group Inc | Healthcare | Medical Devices | 3.54% |
GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.39% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.16% |
ETNB | 89bio Inc | Healthcare | Biotechnology | 3.02% |
ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.32% |
SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.30% |
AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.29% |